S&P DJI Announces March 2019 Quarterly Rebalance
Filed with ASX · · 6 pages · English
Story so far
Earlier from ImpediMed
- Appendix 4C - Quarter ended 31 December 2018
- PREVENT Trial accepted for Publication and Presentation
- Ascension National Purchasing Agreement Received
- Appendix 4C - Quarter ended 30 September 2018
- ImpediMed Completes Asset Sale of XiTRON Technologies, Inc.
Later from ImpediMed
- US Investor Presentation
- Appendix 4C - Quarter ended 31 March 2019
- ASBrS Releases PREVENT Abstract
- PREVENT Interim Results - Practice-Changing
- A$13.9m Fully Underwritten Entitlement Offer Announced
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed